Vax-Before-Travel
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Appointments
Destinations
News
Outbreaks
Vaccines
Prostate Cancer
Fact checked by
Robert Carlson, MD
Mar 23
3 min read
Positive Phase III Study Results Announced in Advanced Prostate Cancer Patients
Novartis 177Lu-PSMA-617 is an investigational PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
Cancer
Prostate Cancer
Fact checked by
Danielle Reiter, RN
Dec 19
5 min read
Innovative Prostate Cancer Treatment Approved by the U.S. FDA
Myovant Sciences Orgovyx is an orally administered treatment that works by blocking the pituitary gland from making hormones
Cancer
Prostate Cancer
Fact check in progress
Dec 3
6 min read
First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer Approved
FDA approved UCLA and CAL’s Gallium 68 PSMA-11 prostate cancer drug
Cancer
Prostate Cancer
Fact check in progress
Dec 3
4 min read
Prostate Cancer Treatment Seeks New Indication Authorization
Janssen Erleada requests FDA approval for the treatment of patients with metastatic castration-sensitive prostate cancer
Cancer
Prostate Cancer
Fact check in progress
Dec 2
5 min read
$5 Million to Launch Prostate Cancer Centers of Excellence
Prostate Cancer Foundation announced a $5 million commitment to launch new Centers of Excellence
Cancer
Prostate Cancer
Show more